Kevin Weil, the former OpenAI executive who led the ChatGPT maker’s AI-for-science efforts, is launching a new startup aimed at using artificial intelligence to speed up a key step of drug development.
Kevin Weil, the former OpenAI executive who led the ChatGPT maker’s AI-for-science efforts, is launching a new startup aimed at using artificial intelligence to speed up a key step of drug development.
<iframe src="https://statesidedaily.com/embed/cluster/e3420fdb921effdb6eb202a26567e9d01e9020e9" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Ex-OpenAI Science Head Kevin Weil Launches Startup With $215 Million"></iframe>
